Gyre Therapeutics, Inc.
GYREHealthcare|Biotechnology|US
$4.76
+0.75 (+18.70%)
Tangible Book / Share
$1.52
Cash / Share
$0.39
Clinical Trials (0)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|